Medical Device Post-Market Surveillance in Thailand

Maintaining compliance, safety, and reliability for your medical devices in Thailand can be complex. That’s where Andaman Medical steps in.

With our expert post-market surveillance services in Thailand, we manage the entire process—from meeting Thai FDA requirements to tracking ongoing product performance and safety. We help ensure your devices remain compliant, trusted, and ready for long-term success in the Thai market.

Why Get Medical Devices PMS in Thailand?

Post-market surveillance goes beyond regulatory compliance. It safeguards patient safety, ensures continued market access, and reinforces confidence in your brand.

At Andaman Medical, we provide end-to-end post-market surveillance (PMS) solutions designed specifically for Thailand’s regulatory framework. With our in-depth knowledge of Thai FDA requirements and the medical device industry, we help you maintain compliance, manage risks proactively, and enhance product quality—all while supporting better health outcomes.

Here’s how Andaman Medical supports your post-market surveillance needs in Thailand:

Medical Device PMS Requirements in Thailand

As part of post-market surveillance of medical devices, Thailand requires the reporting of medical device defects or adverse events (AEs) affecting any person, whether the incident occurs within Thailand or abroad, when the medical device is suspected to be a contributory cause. The reporting is required for the following criteria:

  • serious threat to public health incidents
  • death or serious injury
  • if scientific data or evidence indicates that the incident can lead to death or serious harm to consumers if it were to recur.

In order to reduce or eliminate the risks associated with the medical device defect or AE which can result in a serious threat to public health or imminent risk of death or serious harm, the surveillance and reporting of a FSCA is required when the Product Owner undertakes any of the following actions either in Thailand or outside Thailand:

  • product recall
  • device modification
  • product exchange
  • device destruction
  • safety notification updates and changes.

In order for the Thailand’s FDA to adequately evaluate the cause of the medical device defect or AE, and the subsequent FSCAs, the following information is required as a minimum for the reporting:

  • description of the device defect or AE, and FSCA
  • place where the device defect or Adverse Effect occurred
  • persons affected by the incident (only for AE)
  • health hazard evaluation report or any related documents, together with the initial report (only for FSCA).

The Adverse Effect and FSCA reports can be submitted via the online Medical Device Problem Reporting System on the Health Product Vigilance Centre website.

Timelines for AE and FSCA reporting in Thailand

The Thai FDA stipulates timelines for reporting of the incident or FSCA as below:
Type of Report Timeline
1.1 Adverse Event in Domestic Case Initial report Serious threat to public health:
Immediately or not later than 48 hours
Death or serious injury: 
Immediately or within 10 days
Potential to cause death or serious injury if the event recurs:
Within 30 days
Follow-up report 30 days from initial report
1.2 Adverse Event in Foreign Case Report Twice a year<
(1) Incidents occurring from January to June should be reported within the month of August.
(2) Incidents occurring from July to December should be reported within the month of February of the following year
1.2. FSCA in Thailand and overseas Domestic Case & Foreign Case Initial report Within 48 hours of implementation of the FSCA
Follow-up report Within 21 days of the previous report

Why Choose Andaman Medical
with the Medical Device Post-Market Surveillance in Thailand?

Scroll to Top

Contact Us

Contact Form Demo